Cas no 70918-00-2 (1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine)
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine Chemical and Physical Properties
Names and Identifiers
-
- (2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)(piperazin-1-yl)methanone
- (2,3-DIHYDROBENZO[B][1,4]DIOXIN-3-YL) (PIPERAZIN-1-YL)METHANONE
- (2,3-DIHYDRO-BENZO[1,4]DIOXIN-2-YL)-PIPERAZIN-1-YL-METHANONE
- 2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL(PIPERAZINO)METHANONE
- 1-[(2,3-DIHYDRO-1,4-BENZODIOXAN-2-YL)CARBONYL]PIPERAZINE
- N-[(1,4-BENZODIOXAN-2-YL)CARBONYL]PIPERAZINE
- N-[(1,4-BENZODIOXANE-2-YL)CARBONYL]PIPERAZINE
- 1,4-BENZODIOXAN-2-CARBOXYPIPERAZINE
- 2,3-Dihydro-1,4-Benzodioxan-2Yl-
- 1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine
- 2-(1-Piperazinylcarbonyl)-1,4-benzodioxane
- 1-(2,3-Dihydro-1,4-benzodioxin-2-ylcarbonyl)-piperazine
- 2,3-dihydro-1,4-benzodioxin-3-yl(piperazin-1-yl)methanone
- 1-(1,4-Benzodioxane-2-carbonyl)piperazine
- 1-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazine(SALTDATA: HCl)
- 1-[(1,4-Benzodioxan-2-yl)carbonyl]piperazine
- 1-[(2,3-Dihydro-1,4-benzodiaxan-2-yl)carbonyl]piperazine
- 1-(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YLCARBONYL)PIPERAZINE
- 1-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazine
- 1-(2,3-dihydro-1,4-benzodioxin-2-ylc
- (1,4-benzodioxan-2-yl-carbonyl)piperazine
- n-(1,4-benzodioxan-2-yl-carbonyl)piperazine
- AB14864
- (1,4-benzodioxan-2-ylcarbonyl)piperazine
- 1-(1,4-benzodioxan-2-yl-carbonyl)piperazine
- (+/-)-1-(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YLCARBONYL)PIPERAZINE
- N-(1,4-benzodioxan-2-ylcarbonyl)piperazine
- (2,3-DIHYDROBENZO(B)(1,4)DIOXIN-2-YL)(PIPERAZIN-1-YL)METHANONE
- Maybridge1_005103
- N-[(1,4-benzodioxaN-2-yl)carbonyl]piperazine hydrochloride, AldrichCPR
- 70918-00-2
- AN-708/37277001
- 1-(1 pound not4-Benzodioxane-2-carbonyl)piperazine
- DOXAZOSIN IMPURITY B
- N-(1,4-benzodioxan-2-carbonyl)piperazine
- AKOS016050231
- Oprea1_573270
- 1-((2RS)-2,3-DIHYDRO-1,4-BENZODIOXIN-2-YLCARBONYL)PIPERAZINE
- FT-0630312
- AB29462
- DTXSID10867969
- EC 700-374-1
- P1836
- CS-W010225
- FLUPDJNTYCSBJZ-UHFFFAOYSA-N
- (2,3-Dihydrobenzo(1,4)dioxin-2-yl)piperazin-1-yl-methanone
- Piperazine, 1-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-
- 1-[(2rs)-2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl]piperazine
- A9321
- (2,3-Dihydro-1,4-benzodioxin-2-yl)(piperazin-1-yl)methanone
- HMS1368K05
- Bionet2_001597
- Q27261107
- METHANONE, (2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)-1-PIPERAZINYL-
- UNII-53FEH46OYE
- DOXAZOSIN MESILATE IMPURITY B [EP IMPURITY]
- 1X-0816
- MFCD01837119
- N-1,4-Benzodioxane-2-carbonyl piperazine
- AC-6645
- N-(1,4-benzodioxan-2-carbonyl)-piperazine
- PIPERAZINE, 1-((2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)CARBONYL)-
- EN300-10535
- CCG-251093
- (2,3-dihydrobenzo[b][1,4]dioxin-2-yl) (piperazin-1-yl)methanone
- SCHEMBL610143
- 53FEH46OYE
- BDBM625966
- AKOS000198889
- 1-((2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)CARBONYL)PIPERAZINE
- (2,3-Dihydro-benzo[1,4]dioxin-2-yl)-piperazin-1-yl -methanone
- ALBB-004718
- DB-016269
- BBL004491
- STK501315
- 2,3-dihydro-1,4-benzodioxin-2-yl(piperazin-1-yl)methanone
- N-(1,4-benzodioxan-2-yl-carbonyl)piperazine;1-(2,3-Dihydro-1,4-Benzodioxin-2-Ylcarbonyl)Piperazine
-
- MDL: MFCD01837119
- Inchi: 1S/C13H16N2O3/c16-13(15-7-5-14-6-8-15)12-9-17-10-3-1-2-4-11(10)18-12/h1-4,12,14H,5-9H2
- InChI Key: FLUPDJNTYCSBJZ-UHFFFAOYSA-N
- SMILES: O1C2C=CC=CC=2OCC1C(N1CCNCC1)=O
Computed Properties
- Exact Mass: 248.11600
- Monoisotopic Mass: 248.116
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 18
- Rotatable Bond Count: 1
- Complexity: 305
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 0.7
- Topological Polar Surface Area: 50.8
Experimental Properties
- Color/Form: White or light brown powder
- Density: 1.246
- Melting Point: 103.0 to 107.0 deg-C
- Boiling Point: 437.2 °C at 760 mmHg
- Flash Point: 218.2 °C
- PSA: 50.80000
- LogP: 0.52490
- Solubility: Not determined
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine Security Information
-
Symbol:
- Prompt:warning
- Signal Word:Danger
- Hazard Statement: H315-H319
- Warning Statement: P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313
- Hazard Category Code: 23/24/25-48/22-51/53
- Safety Instruction: 53-45-61
-
Hazardous Material Identification:
- HazardClass:IRRITANT
- Storage Condition:2-8 °C
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine Customs Data
- HS CODE:2934999090
- Customs Data:
China Customs Code:
2934999090Overview:
2934999090. Other heterocyclic compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to
Summary:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM115580-25g |
1-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazine |
70918-00-2 | 95% | 25g |
$327 | 2021-08-06 | |
| Fluorochem | 011689-5g |
2,3-Dihydro-benzo[1,4]dioxin-2-yl)-piperazin-1-yl-methanone |
70918-00-2 | 95% | 5g |
£72.00 | 2022-03-01 | |
| AstaTech | 58429-1/G |
(2,3-DIHYDRO-BENZO[1,4]DIOXIN-2-YL)-PIPERAZIN-1-YL-METHANONE |
70918-00-2 | 98% | 1g |
$94 | 2023-09-16 | |
| AstaTech | 58429-5/G |
(2,3-DIHYDRO-BENZO[1,4]DIOXIN-2-YL)-PIPERAZIN-1-YL-METHANONE |
70918-00-2 | 98% | 5g |
$188 | 2023-09-16 | |
| AstaTech | 58429-25/G |
(2,3-DIHYDRO-BENZO[1,4]DIOXIN-2-YL)-PIPERAZIN-1-YL-METHANONE |
70918-00-2 | 98% | 25/G |
$667 | 2022-02-28 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | B133994-1g |
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine |
70918-00-2 | ≥95.0%(GC) | 1g |
¥198.90 | 2023-09-04 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | B133994-5g |
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine |
70918-00-2 | ≥95.0%(GC) | 5g |
¥792.90 | 2023-09-04 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R030612-5g |
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine |
70918-00-2 | 95% | 5g |
¥951 | 2024-05-22 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R030612-1g |
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine |
70918-00-2 | 95% | 1g |
¥234 | 2024-05-22 | |
| TRC | B203400-1g |
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine |
70918-00-2 | 1g |
$ 135.00 | 2022-06-07 |
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine Suppliers
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine Related Literature
-
C. S. Karthik,H. M. Manukumar,S. Sandeep,B. L. Sudarshan,S. Nagashree,L. Mallesha,K. P. Rakesh,K. R. Sanjay,P. Mallu,Hua-Li Qin Med. Chem. Commun. 2018 9 713
Additional information on 1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine
Comprehensive Overview of 1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine (CAS No. 70918-00-2): Properties, Applications, and Research Insights
1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine (CAS No. 70918-00-2) is a specialized organic compound that has garnered significant attention in pharmaceutical and chemical research due to its unique structural features and potential applications. This compound, often referred to by its systematic name or CAS number, belongs to the class of benzodioxane derivatives, which are known for their diverse biological activities. The presence of both a benzodioxane moiety and a piperazine ring in its structure makes it a versatile intermediate in drug discovery and material science.
In recent years, the demand for 1,4-benzodioxane-based compounds has surged, driven by their relevance in designing central nervous system (CNS) therapeutics and GPCR-targeted drugs. Researchers frequently search for "benzodioxane piperazine derivatives" or "CAS 70918-00-2 applications" to explore its role in modern pharmacology. The compound's molecular weight (276.3 g/mol) and lipophilicity (LogP ≈ 1.8) align with the Lipinski's Rule of Five, making it a promising candidate for oral drug development.
The synthesis of 1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine typically involves the condensation of 1,4-benzodioxane-2-carboxylic acid with piperazine under peptide coupling conditions. Its crystalline form and solubility profile (soluble in DMSO, methanol) have been characterized in multiple patent literature and journal publications. A trending topic in 2023-2024 is its potential utility in neuroprotective agents, as evidenced by its structural similarity to known adenosine receptor ligands.
From an industrial perspective, 70918-00-2 is often cataloged by suppliers as a high-purity reference standard for analytical testing. Laboratories frequently inquire about "1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine HPLC methods" or "stability under accelerated conditions," reflecting its importance in quality control. The compound's UV absorption maxima (λmax 280 nm) and mass spectrometry fragmentation patterns are well-documented for analytical validation.
Emerging studies suggest that modifications of the piperazine carbonyl group in this scaffold could enhance blood-brain barrier permeability—a hot topic in Alzheimer's disease research. Computational chemistry models predict moderate protein binding affinity (~85%), sparking interest in its use as a pharmacophore in multi-target drug design. Notably, its thermal stability (decomposition >200°C) makes it suitable for high-temperature reactions in process chemistry.
Environmental and regulatory aspects of CAS 70918-00-2 are also frequently searched. The compound is not classified under REACH restrictions, but proper laboratory handling protocols are recommended due to its potential irritant properties. Recent green chemistry initiatives have explored solvent-free synthesis routes to improve its E-factor in industrial production.
In conclusion, 1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine represents a compelling case study in medicinal chemistry innovation. Its dual functionality as a hydrogen bond acceptor (via piperazine) and aromatic stabilizer (via benzodioxane) continues to inspire research across drug discovery, material science, and analytical method development. Future directions may explore its structure-activity relationships through AI-driven molecular modeling—a cutting-edge approach aligning with 2024's focus on computational drug design.
70918-00-2 (1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine) Related Products
- 617677-53-9(N,N’-Bis(1,4-benzodioxane-2-carbonyl)piperazine)
- 860173-98-4((R)-1,4-Benzodioxan-2-Carboxypiperazine)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)